Fig. 7: CysLT1R controls eosinophilia and ST2+IL-17+ ILC2 accumulation in Rbm3−/− mice. | Nature Communications

Fig. 7: CysLT1R controls eosinophilia and ST2+IL-17+ ILC2 accumulation in Rbm3−/− mice.

From: RNA-binding protein RBM3 intrinsically suppresses lung innate lymphoid cell activation and inflammation partially through CysLT1R

Fig. 7: CysLT1R controls eosinophilia and ST2+IL-17+ ILC2 accumulation in Rbm3−/− mice.

WT and Rbm3-/- mice were challenged with 25 µg Alternaria three times over 7 days. Lin-Thy1.2+ ILCs were FACS-sorted and bulk RNA-sequenced. Data representative of three mice per group. a Relative transcript levels of select ILC transcripts b PCA plot of WT (blue) and Rbm3−/− (red) samples. c TPMs of select surface marker, cytokine, and transcription factor transcripts. Unpaired t-test, two-tailed. *p < 0.05, **p < 0.01, ***p < 0.001. d Wild-type, Rbm3−/−, and Rbm3−/−Cyslt1r−/− mice were challenged with Alternaria three times over 14 days. Total type 2 cytokine-producing ILC2s, IL17 producing ST2+ILCs, and BAL and lung eosinophils in WT, Rbm3−/−, and Rbm3−/−Cysltr1−/− mice, One-way ANOVA. *p < 0.05, **p < 0.01, ***p < 0.001. Data are presented as mean values+/ SEM.

Back to article page